January 19, 2024 · Form 4 insider transaction
Dissanaike Sharmila bought 83,685 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.